Research, led by scientists at the Hansen Experimental Physics Laboratory, Stanford University, has demonstrated clinically relevant retinal responses from experimental animal models following implantation of… Read More »Photovoltaic restoration of sight with high visual acuity in animal models of retinal degeneration
Inherited retinal disorders (IRDs) are estimated to affect millions of individuals on a global scale, in many instances leading to significantly reduced vision or blindness.… Read More »Converting rods into cones in a model of retinitis pigmentosa (RP) rescues retinal degeneration
Ocata Therapeutics Inc., (formerly Advanced Cell Technology), a regenerative cell therapy company focused on ophthalmic disorders, has announced the execution of a licensing deal for… Read More »Ocata Therapeutics licenses induced pluripotent stem cell (iPSC) technology from Allele Biotechnology Inc.
A recent publication on clinical trial results arising from industry-sponsored head-to-head studies has concluded that problems continue to persist with industry-funded studies. The analysis, led… Read More »Analysis of head to head comparative clinical trials sponsored by industry show strong association with favourable results
Research, led by scientists at the Hong Kong University of Science and Technology in China, has shown that a new hydrogel based formulation is capable… Read More »Controlled release of bevacizumab (Avastin) in experimental model indicates potential benefits for clinical practice
Inherited retinal disorders (IRDs) are estimated to affect millions of individuals on a global scale, in many instances leading to significantly reduced vision or blindness.… Read More »Converting rods into cones in a model of retinitis pigmentosa (RP) rescues retinal degeneration
Ophthotech Corporation (Nasdaq: OPHT) has announced that it has reached a second $50 million milestone payment from Novartis Pharma AG as part of an ex-US… Read More »Ophthotech Corporation receives $50M milestone payment from Novartis for development of Fovista
Clinical research led by a Japanese team at Kyushu University Graduate School of Medical Sciences, Fukuoka, has suggested that overexpression of CD163 in the vitreous… Read More »Biomarker involved in proliferative diabetic retinopathy (PDR) highlights potential role of M2 macrophage
Research led by scientists at Wayne State University, Detroit, Michigan, has demonstrated that salicylate may improve retinal function by enhancing insulin signaling in the retina… Read More »Sodium salicylate improves retinal function and reduces insulin resistance in retina of type 2 diabetic models
A research team from the Hebrew University of Jerusalem recently demonstrated that the same part of the visual cortex activated in sighted individuals when reading… Read More »Congenitally blind patients reading “through sound” show activation of visual cortex in the brain including response to colour.